Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...

The US Food and Drug Administration (FDA) has unveiled a new programme that will reduce its review time for certain drug ...

For years, women have been significantly underrepresented in clinical trials, despite making up a large portion of patients ...

AstraZeneca (AZ) has announced promising results from a late-stage study of its C5 complement inhibitor Ultomiris ...

Last month, the ISPOR annual meeting in Montreal was brimming with opportunities to explore the latest developments and ...

In 2025, data protection is more important than ever. Yet, many in the pharma industry are still behind when it comes to ...

In today’s fast-paced experience economy, pharma companies can no longer rely on static displays and outdated engagement ...

Roche has announced that it will be advancing its Prothena-partnered investigational Parkinson’s disease (PD) drug ...

Novartis has shared positive results from a phase 3b study of Fabhalta (iptacopan) in a new population of patients with the ...

Medscape Education, a global leader in healthcare education, proudly announces the official launch of its Center of ...

AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the US Food and Drug Administration (FDA) ...